Influence of Short-term Vojta Therapy on the Gait in Healthy Adult Subjects. (V&G)

August 25, 2021 updated by: NUMEN Foundation
The patterns of reflex locomotion described by Vojta contain all the basic patterns necessary for gait, which can be observed as partial patterns during normal postural ontogenesis in the first year of life. These patterns are triggered throughout life regardless of age, so they can be activated both in healthy subjects and in the presence of neurological pathology in adult patients.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

In reflex locomotion, there is a coordinated and rhythmic activation of the entire skeletal muscles and different circuits of the central nervous system are stimulated. The motor reactions that are triggered regularly and cyclically due to pressure stimuli, from certain starting positions, are completely reproducible and as often as desired, even in the newborn child.

All the movements that appear in the development of the human being in grasping, turning, crawling, standing up and walking, are therefore visibly stimulated. They are, according to Prof. Vojta, present even in children of a developmental stage, in which they do not spontaneously yet possess these capacities.

Through the therapeutic application of reflex locomotion, those muscular functions used unconsciously and necessary for spontaneous daily motor skills are activated in the patient, especially in the spine, but also in the arms and legs, hands and feet and in the face.

Study Type

Interventional

Enrollment (Anticipated)

43

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • To be over 18 years old.

Exclusion Criteria:

  • Present limitations or permanent or temporary injuries to the locomotor system.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vojta Therapy
In Vojta therapy, the therapist selectively presses certain areas of the body, with the patient lying prone, - supine or - lateral. These types of stimuli, in humans of any age, provoke automatically and without their own initiative, that is, without the active voluntary collaboration of the person
Other: Vojta Therapy
Reflex locomotion is activated by the "reflexogenic" pathway. In context with reflex locomotion, the term "reflex" does not represent the mode of neuronal control, but rather refers to defined, "automatic" and always equal motor responses produced by external stimuli, applied therapeutically.
Other Names:
  • Reflex Locomotion
Placebo Comparator: Control Group
In the control group, a placebo intervention is administered, similar to an experimental intervention
Other: placebo
In the control group, a placebo intervention is administered, similar to an experimental intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6 Minutes walk
Time Frame: one month
walk for 6 minutes measuring the meters walked
one month
EMG surface
Time Frame: two month
surface electromyography in four muscles
two month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

NUMEN Foundation

Collaborators

Universidad Europea de Madrid

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 25, 2021

Primary Completion (Anticipated)

December 30, 2021

Study Completion (Anticipated)

May 15, 2022

Study Registration Dates

First Submitted

December 28, 2020

First Submitted That Met QC Criteria

December 28, 2020

First Posted (Actual)

December 30, 2020

Study Record Updates

Last Update Posted (Actual)

August 26, 2021

Last Update Submitted That Met QC Criteria

August 25, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Numen2

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gait, Frontal

Clinical Trials on Vojta Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe